tamibarotene has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, M; Kodama, T; Komai, K; Koshida, R; Morita, R; Noguchi, Y; Ooboshi, H; Shichita, T; Takahashi, S; Yoshimura, A | 1 |
| An, R; Dong, Z; Li, M; Luo, Y; Tian, X; Xu, L | 1 |
2 other study(ies) available for tamibarotene and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1.
Topics: Alarmins; Animals; Benzoates; Brain; Brain Ischemia; Calgranulin A; Calgranulin B; Chromatin Immunoprecipitation; CRISPR-Cas Systems; HMGB1 Protein; Infarction, Middle Cerebral Artery; Inflammation; MafB Transcription Factor; Mice; Myeloid Cells; Peroxiredoxins; Receptors, Immunologic; Receptors, Retinoic Acid; Scavenger Receptors, Class A; Stroke; Tetrahydronaphthalenes | 2017 |
Tamibarotene Improves Hippocampus Injury Induced by Focal Cerebral Ischemia-Reperfusion via Modulating PI3K/Akt Pathway in Rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Benzoates; Disease Models, Animal; Hippocampus; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Tetrahydronaphthalenes | 2019 |